338 related articles for article (PubMed ID: 8995372)
21. Activation of protein phosphorylation by oxidants in vascular endothelial cells: identification of tyrosine phosphorylation of caveolin.
Vepa S; Scribner WM; Natarajan V
Free Radic Biol Med; 1997; 22(1-2):25-35. PubMed ID: 8958127
[TBL] [Abstract][Full Text] [Related]
22.
Machado LESF; Page R; Peti W
Biomol NMR Assign; 2018 Apr; 12(1):5-9. PubMed ID: 28856606
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of nuclear factor-kappaB activation and protein tyrosine phosphorylation by a tyrosine phosphatase inhibitor, pervanadate, involves reactive oxygen species in silica-stimulated macrophages.
Kang JL; Pack IS; Lee HS; Castranova V
Toxicology; 2000 Oct; 151(1-3):81-9. PubMed ID: 11074303
[TBL] [Abstract][Full Text] [Related]
24. Vanadate inhibition of protein tyrosine phosphatases in Jurkat cells: modulation by redox state.
Cuncic C; Detich N; Ethier D; Tracey AS; Gresser MJ; Ramachandran C
J Biol Inorg Chem; 1999 Jun; 4(3):354-9. PubMed ID: 10439081
[TBL] [Abstract][Full Text] [Related]
25. Possible involvement of a tyrosine kinase-dependent pathway in the regulation of phosphoinositide metabolism by vanadate in normal mouse islets.
Jonas JC; Henquin JC
Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):49-55. PubMed ID: 8670131
[TBL] [Abstract][Full Text] [Related]
26. Activation and inactivation of the volume-sensitive taurine leak pathway in NIH3T3 fibroblasts and Ehrlich Lettre ascites cells.
Lambert IH
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C390-400. PubMed ID: 17537804
[TBL] [Abstract][Full Text] [Related]
27. Protein phosphotyrosine phosphatase inhibitors suppress regulatory volume decrease and the volume-sensitive Cl- conductance in mouse fibroblasts.
Thoroed SM; Bryan-Sisneros A; Doroshenko P
Pflugers Arch; 1999 Jul; 438(2):133-40. PubMed ID: 10370098
[TBL] [Abstract][Full Text] [Related]
28. Vanadate inhibition of protein tyrosine phosphatases mimics hydrogen peroxide in the activation of the ERK pathway in alveolar macrophages.
Torres M; Forman HJ
Ann N Y Acad Sci; 2002 Nov; 973():345-8. PubMed ID: 12485891
[No Abstract] [Full Text] [Related]
29. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite.
Takakura K; Beckman JS; MacMillan-Crow LA; Crow JP
Arch Biochem Biophys; 1999 Sep; 369(2):197-207. PubMed ID: 10486138
[TBL] [Abstract][Full Text] [Related]
30. Pervanadate stimulates amylase release and protein tyrosine phosphorylation of paxillin and p125(FAK) in differentiated AR4-2J pancreatic acinar cells.
Feick P; Gilhaus S; Schulz I
J Biol Chem; 1998 Jun; 273(26):16366-73. PubMed ID: 9632700
[TBL] [Abstract][Full Text] [Related]
31. Relationship between phosphatase activity and cytotoxic effect of two protein phosphatase inhibitors, okadaic acid and pervanadate, on human myeloid leukemia cell line.
Freire AC; Aoyama H; Haun M; Ferreira CV
J Enzyme Inhib Med Chem; 2003 Oct; 18(5):425-9. PubMed ID: 14692510
[TBL] [Abstract][Full Text] [Related]
32. Altered actin cytoskeleton and inhibition of matrix metalloproteinase expression by vanadate and phenylarsine oxide, inhibitors of phosphotyrosine phosphatases: modulation of migration and invasion of human malignant glioma cells.
Chintala SK; Kyritsis AP; Mohan PM; Mohanam S; Sawaya R; Gokslan Z; Yung WK; Steck P; Uhm JH; Aggarwal BB; Rao JS
Mol Carcinog; 1999 Dec; 26(4):274-85. PubMed ID: 10569804
[TBL] [Abstract][Full Text] [Related]
33. Activation of mesangial cells by the phosphatase inhibitor vanadate. Potential implications for diabetic nephropathy.
Wenzel UO; Fouqueray B; Biswas P; Grandaliano G; Choudhury GG; Abboud HE
J Clin Invest; 1995 Mar; 95(3):1244-52. PubMed ID: 7883973
[TBL] [Abstract][Full Text] [Related]
34. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells.
Chen WL; Harris DL; Joyce NC
Exp Eye Res; 2005 Nov; 81(5):570-80. PubMed ID: 15950220
[TBL] [Abstract][Full Text] [Related]
35. Modulation of cyclin D1 and its signaling components by the phorbol ester TPA and the tyrosine phosphatase inhibitor vanadate.
Yan S; Wenner CE
J Cell Physiol; 2001 Mar; 186(3):338-49. PubMed ID: 11169972
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine phosphorylation and proteolysis. Pervanadate-induced, metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin.
Vecchi M; Rudolph-Owen LA; Brown CL; Dempsey PJ; Carpenter G
J Biol Chem; 1998 Aug; 273(32):20589-95. PubMed ID: 9685416
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of protein tyrosine phosphatases causes phosphorylation of tyrosine-331 in the p60 TNF receptor and inactivates the receptor-associated kinase.
Darnay BG; Aggarwal BB
FEBS Lett; 1997 Jun; 410(2-3):361-7. PubMed ID: 9237663
[TBL] [Abstract][Full Text] [Related]
38. Crystal structure of bovine low molecular weight phosphotyrosyl phosphatase complexed with the transition state analog vanadate.
Zhang M; Zhou M; Van Etten RL; Stauffacher CV
Biochemistry; 1997 Jan; 36(1):15-23. PubMed ID: 8993313
[TBL] [Abstract][Full Text] [Related]
39. Reactive oxygen species mediate phorbol ester-regulated tyrosine phosphorylation and phospholipase A2 activation: potentiation by vanadate.
Zor U; Ferber E; Gergely P; Szücs K; Dombrádi V; Goldman R
Biochem J; 1993 Nov; 295 ( Pt 3)(Pt 3):879-88. PubMed ID: 7694572
[TBL] [Abstract][Full Text] [Related]
40. Cross-talk between adenylate cyclase activation and tyrosine phosphorylation leads to modulation of the actin cytoskeleton and to acute progesterone secretion in ovarian granulosa cells.
Aharoni D; Dantes A; Amsterdam A
Endocrinology; 1993 Sep; 133(3):1426-36. PubMed ID: 7689957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
